Delivery Order SPE2DX22D0029-SPE2D826F12PH
- Not listed
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,576.80 by the Defense Logistics Agency's Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,189.11 by the Defense Logistics Agency's Medical Supply Chain on January 1, 2026. This competitive, non-set-aside contract features firm fixed pricing and is scheduled for completion by January 2, 2026. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,352.12 on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract, which uses firm fixed-price pricing with no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,671.88 on June 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. The competitively awarded, firm fixed-price contract carries an ultimate completion date of June 20, 2025, and represents a child order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order falls within...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,055.58 on October 1, 2025, with an ultimate completion date of October 2, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, issued by the Defense Logistics Agency's Medical Supply Chain in support of federal pharmaceutical and medical supply procurement. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,756.24 by the Defense Logistics Agency's Medical Supply Chain on September 18, 2025. The contract, which represents a child order under a larger indefinite delivery vehicle, involves firm fixed pricing with no set-aside designation and an ultimate completion date of September 19, 2025. As a critical vendor for federal medical procurement,...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $92,138.57 on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract, issued under a firm fixed-price arrangement with no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying pharmaceutical products and medical commodities to...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F12PHDelivery Order
This delivery order, awarded on January 7, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency's Medical Supply Chain, carries a ceiling value of $1,125.84 and a firm fixed price structure. The award is unset-aside and represents a competitive delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city, with an ultimate completion date of January 8, 2026. AmerisourceBergen maintains a significant presence in federal pharmaceutical procurement through its $999,999,999.00 IDC with DLA Troop Support Medical, which serves as the primary vehicle for supplying pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to military healthcare programs globally. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, specialty drugs, and medical devices across multiple therapeutic domains to defense healthcare systems, including the Defense Health Agency and U.S. Coast Guard, positioning it as a critical vendor for federal military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/6/26 |